Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Jiangxi Boya Bio-Pharmaceutical Co Ltd

+ Add to Watchlist

300294:CH

73.020 CNY 0.920 1.28%

As of 02:00:30 ET on 03/04/2015.

Snapshot for Jiangxi Boya Bio-Pharmaceutical Co Ltd (300294)

Open: 72.040 Day's Range: 71.690 - 74.770 Volume: 1,378,837
Previous Close: 72.100 52wk Range: 39.980 - 78.870 1-Yr Rtn: +57.95%

Stock Chart for 300294

No chart data available.
  • 300294:CH 73.020
  • 1D
  • 1M
  • 1Y
72.100
Interactive 300294 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300294

Current P/E Ratio (ttm) 53.2993
Estimated P/E(12/2015) 53.2993
Relative P/E vs. SZ399006 0.7012
Earnings Per Share (CNY) (ttm) 1.3700
Est. EPS (CNY) (12/2015) 1.3700
Est. PEG Ratio -
Market Cap (M CNY) 5,534.92
Shares Outstanding (M) 75.80
30 Day Average Volume 1,088,180
Price/Book (mrq) 6.4480
Price/Sale (ttm) 12.7577
Dividend Indicated Gross Yield 0.82%
Cash Dividend (CNY) 0.6000
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300294

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300294

Jiangxi Boya Bio-Pharmaceutical company Limited develops, produces and sells blood product. The Company's main products include human serum albumin, intravenous immunoglobulin (static C) and fibrinogen.

Xu JianxinChairmanLiao XinxiPresident
Liang XiaomingExecutive VPDuan HongzhuanVice President
More Company Profile & Key Executives for 300294

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil